Abstract:Angiogenesis is under the exquisite control of a network of angiogenic factors and anti-angiogenic factors. PEDF (pigment epithelial derived factor) is one of the known anti-angiogenesis factors and is naturally occurring in the body. There has been studies to show that the factor plays an important role in negating the angiogenic process in pathological conditions in the eye. However, little is known about its expression in solid tumors. The current study examined PEDF expression at protein and message levels and investigated its critical link with cancer progression and prognosis in patients with non-small cell lung cancer (NSCLC). We used immunohistochemistry to examine the protein expression of PEDF and to evaluate the microvessel density (MVD) in a cohort of 91 NSCLC patients. In addition, real-time quantitative PCR was used to measure levels of the PEDF transcript. PEDF was positively stained in cytoplasm of cancer cells, but at a lower level, compared with normal cells in the lung tissues. Low levels of PEDF were seen in 57.1% patients. The levels of PEDF appeared to be associated with MVD, in that patients with reduced PEDF had a significantly high MVD count (28.50), compared with patients with high levels of PEDF who had a 16.98 MVD count (p<0.0005). In univariate but not multivariate analysis PEDF was an independent prognostic factor. In real-time PCR analysis, PEDF mRNA level of cancer tissue was significantly lower than normal tissue (0.55+/-0.36 vs 0.72+/-0.26, p=0.024, paired t-test). PEDF mRNA level in cancer tissue was negatively associated with TNM stage and the tumor size (p<0.05, independent t-test). Finally, low levels of PEDF in lung tumor tissues was associated with a significantly shorter survival (p=0.038) using Kaplan-Meier and Cox analyses. In this first study, PEDF was reduced at both protein and mRNA level in NSCLC tumors compared with normal lung tissues. This reduction is associated with an increase in microvessel density in tumors and significantly associated with TNM stage, tumor size and the overall survival. PEDF is an important factor in NSCLC development and may be a of prognostic value for NSCLC patients.

Cdna Microarray Analysis of Pigment Epithelium-Derived Factor-Regulated Gene Expression Profile in Prostate Carcinoma Cells.

Pigment Epithelial-Derived Factor Expression in Endometriotic Lesions in a Rat Model of Endometriosis.

[Inhibition and Significance of Pigment Epithelium-Derived Factor in the Development and Metastasis of Prostate Cancer].

Adenovirus-mediated PEDF Expression Inhibits Prostate Cancer Cell Growth and Results in Augmented Expression of PAI-2.

Pigment epithelium-derived factor plays an inhibitory role in proliferation and migration of HaCaT cells

The Molecular Impact Of Pigment Epithelium-Derived Factor, Pedf, On Lung Cancer Cells And The Clinical Significance

Expression of Pigment Epithelium-Derived Factor in Human Cutaneous Appendages

Pigment Epithelium Derived Factor Inhibits the Growth of Human Endometrial Implants in Nude Mice and of Ovarian Endometriotic Stromal Cells in Vitro

Expression of Pigment Epithelial Derived Factor is Reduced in Non-Small Cell Lung Cancer and is Linked to Clinical Outcome.

Proapoptotic PEDF Functional Peptides Inhibit Prostate Tumor Growth--a Mechanistic Study.

[Effects of Pigment Epithelial Derived Factor Gene on Growth of Lung Cancer Cell and Neovascularization: Experiments with Lung Cancer Cells and Chick Embryos].

The Expression of PEDF in Bladder Cancer and Its Clinical Significance

Expression of Angiogenic Inhibitors in Benign Prostate Hyperplasia and Prostate Cancer

Down-regulation of PEDF expression by ribozyme transgene in endothelial and lung cancer cells and its impact on angiogenesis in vitro.

Prognostic role of pigment epithelium-derived factor in clear cell renal cell carcinoma.

Expression of Pigment Epithelium-Derived Factor and Vascular Endothelial Growth Factor in Benign Prostatic Hyperplasia

Pigment epithelium-derived factor inhibits T24 bladder cancer cell growth in vitro and in vivo

Downregulation of Pigment Epithelium-Derived Factor is Associated with Increased Epithelial-Mesenchymal Transition in Bladder Cancer.

Prognostic Value Of Pigment Epithelium-Derived Factor For Neoadjuvant Radiation Therapy In Patients With Locally Advanced Rectal Carcinoma

The expression of pigment epithelium-derived factor and vascular endothelial growth factor in pancreatic carcinoma

Correlation of Pigment Epithelium-Derived Factor Mrna Expression and Recurrence of Bladder Cancer